The increasingly common practice of using a synthetic form of the hormone EPO to maintain normal red blood cell levels in chronic kidney disease patients may increase cardiovascular risks, according ...

Kyoto – A research team at Kyoto University has revealed characteristic behaviors of erythropoietin (Epo)-producing cells. Epo is a hormone produced by the kidney that stimulates red blood cell ...

John A. Moran Eye Center researchers continue to shed new light on the potential of the hormone erythropoietin (EPO) to treat eye disease. EPO increases red blood cell production, and is already used ...

Adding erythropoietin to cooling therapy for term newborns with birth asphyxia has no benefit over cooling therapy alone, a study published today in the New England Journal of Medicine. The findings ...

The important role of the hormone erythropoietin (EPO), which works to increase red blood cell production, in treating anemia has been known for decades. But as clinical trials examine EPO as a ...

Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, No. 13 (Jun. 22, 1999), pp. 7569-7574 (6 pages) Applying a homology search method previously described, we ...

Since 1989, physicians have prescribed the hormone erythropoietin (EPO) to combat anemia from blood loss, kidney failure, and cancer treatments. This compound orchestrates red blood cell production.

The hormone erythropoietin (Epo) is a well-known doping substance that has a history of abuse in endurance sports. In addition to promoting red blood cell production, Epo protects nerve cells from ...